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ABSTRACT  
Objective: The present study was undertaken to evaluate the protective effect of naringenin (Ng) against arsenic (As)-induced oxidative stress in 
the liver of experimental rats. Arsenic is a major environmental pollutant and is known for its wide toxic manifestations. Naringenin is a naturally 
occurring citrus flavonone which has been reported to have a wide range of pharmacological properties. 
Methods: Forty male rats were randomly divided into four groups where the first was served as a control, whereas the remaining groups were 
respectively treated with naringenin (50 mg/kg b.w.), sodium arsenite (5.55 mg/kg b.w.) and a combination of sodium arsenite and naringen. 
Results: Exposure of rats to (As) caused a significant increase in liver MDA level compared to control, but the coadministration of (Ng) was effective 
in reducing its level. The enzymatic activities of glutathione peroxidase (GPx), and glutathione-S-transferase (GST), superoxide dismutase (SOD) and 
catalase(CAT)of As-treated group were found to be lower compared to the control and the (Ng)-treated group. On the other hand, a significant 
increase in activities of AST, ALT and ALP were observed in As-treated group. The co-administration of (Ng) has decreased the activities of AST, ALT 
and ALP and thus co-administration of (Ng) had an additive protective effect on liver enzyme activities and improved the antioxidant status as well. 
Conclusion: To conclude, the results suggest that As exposure enhanced an oxidative stress by disturbing the tissue antioxidant defense system, but 
the (Ng) co-administration protected liver tissues against As intoxication probably owing to its antioxidant properties. 
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INTRODUCTION 
Arsenic is a naturally occurring element that is ubiquitously present in 
the environment in both organic and inorganic forms. Millions of 
people worldwide are at risk of many diseases [1, 2]. Human 
exposures to the generally more toxic inorganic arsenic compounds 
occur in occupational or environmental settings, as well as through the 
medicinal use of arsenicals [3]. Drinking water and industrial pollution 
are major sources of exposure to inorganic arsenic for humans. 
Once ingested, soluble forms of arsenic are readily absorbed from 
the gastrointestinal tract into the blood stream and then distributed 
to organs and tissues after first passing through the liver. Generally, 
As interferes with a number of organ and body functions such as the 
central nervous system [4] and liver and kidneys [5]. However, As-
induced skins lesions are characterized by symptoms like 
hyperpigmentation and keratosis. Other clinical manifestations 
include Blackfoot disease, diabetes mellitus [6], hypertension [7], 
atherosclerosis [9], and cancers of the skin, lung, bladder and liver [7]. 
The acute and chronic toxicity largely depends on the chemical form 
and physical state of the compound involved [8]. Inorganic trivalent 
arsenic is generally regarded as being more toxic than pentavalent 
arsenic, which in turn is more toxic than methylated form.  
The toxicity of inorganic arsenic appears to be mediated through its 
ability to substitute phosphate groups, affecting enzymes that depend on 
this group for their activity (e. g., interfering with the synthesis of ATP 
and DNA). However, As generates ROS and free radicals like hydrogen 
peroxide (H2O2) [11], hydroxyl radical species (HO•), nitric oxide (NO•) 
(Gurr et al., 1998), superoxide anion (O2) [12], dimethyl arsenic peroxyl 
radical ([CH3) 2 AsOO]) and dimethyl arsenic radical [(CH3)2As•] [13]. 
There is a proposal that all of these reactive species generated by As are 
responsible for the oxidative stress responses [10, 14]. 
Thus, it is believed that antioxidant should be one of the important 
components of an effective treatment of as poisoning. There is an 
increasing interest towards the use of naturally occurring 
phytochemicals with hepatoprotective and antioxidant activity in Cd 
intoxication therapy. So for numerous metal-chelating agents and 
synthetic antidotes have been employed to reduce the toxic oxidative 
burden by cadmium [15].  
Flavonoids are one of the most numerous and widespread group of 
naturally occurring antioxidants and as potent inhibitors of lipid 
peroxidation in a biological membrane. They are found in fruits, 
vegetables, nuts, seeds, leaves, flowers, and barks of plants. They 
usually contain one or more aromatic hydroxyl groups in their moiety 
which is responsible for the antioxidant activity of flavonoids [16]. 
Naringenin (40, 5, 7-trihydroxyflavonone) is a plant bioflavonoid 
found in grapefruit, tomato, and citrus fruits. Naringenin has already 
been pharmacologically evaluated as a potential anticancer [17], 
antiatherogenic [18], hepatoprotective [18] and nephro protective 
activities [19]. Naringenin may modulate cytochrome P450-dependent 
monooxygenase, the primary enzyme involved in the metabolism of 
many xenobiotics [20]. In addition Van Acker et al.(2000) reported that 
the aglycone of naringin, naringenin can assume the role of α-tocopherol 
as a chain-breaking antioxidant in the liver microsomal membrane. 
In the event that oxidative stress can be partially implicated in 
arsenic toxicity, a therapeutic strategy to increase the antioxidant 
capacity of cells against arsenic poisoning. This may be 
accomplished by either reducing the possibility of metal interacting 
with critical biomolecules and inducing oxidative damage or by 
boosting the cell’s antioxidant defences through endogenous 
supplementation of antioxidant molecules [21]. Although many 
investigators have confirmed that arsenic induces the oxidative 
stress, the usefulness of antioxidants has recently been considered 
as a better treatment. Therefore, supplementation of antioxidants 
such as (Ng) in the present study was found to be more effective 
against the oxidative damage induced by AS. 
MATERIALS AND METHODS 
Chemicals 
Sodium arsenite (NaAsO2) and Naringenin (Ng) were purchased 
from Sigma Chemical Co. and all other chemicals used in the 
experiment were of analytical grade. 
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Animals and experimental design 
Forty male Wistar rats (weighing 200–220 g) were obtained from 
the Fahad Kingdom center for scientific research–King Abd El-Aziz 
University–Jeddah–Saudi Arabia. I have followed the European 
community Directive (86/609/EEC) and national rules on animal 
care that was carried out in accordance with the NIH Guidelines for 
the Care and Use of Laboratory Animals 8th edition. Animals were 
acclimated for 2 w under the same laboratory conditions of 
photoperiod (12 h light: 12 h dark) with a minimum relative 
humidity of 40 % and room temperature of 25±2 °C. Food and water 
were provided ad libitum. Rats were randomly divided into four 
groups of ten males each. The first group was served as the control. 
The second group (As) was intraperitoneally given sodium arsenite 
(NaAsO2) at a dose of 5.55 mg/kg b. w/day. While the third group 
was given (Ng) at a dose (50 mg/kg b. w). Finally, the fourth group 
was given (As in combination with Ng) was treated daily with both 
As (5.55 mg/kg b. w) and (Ng) at a dose (50 mg/kg b. w) as in 
groups two and three. However, the treatment of all groups lasted 
for 4 consecutive weeks. The dose of NaAsO2 and the period of 
treatment were selected on the basis of previous studies [22]. The 
selection of the dose of naringenin was based on previously 
published reports, where the dose was reported to be effective in 
preventing diverse biological and pharmacological properties [23]. 
At the end of the experiment, animals were sacrificed by cervical 
decapitation without anesthesia to avoid animal stress, and then 
livers were immediately removed and weighed, in order to obtain 
the organ weight ratio. Blood samples were collected in EDTA tubes 
and centrifuged at 2200×g for 15 min at 4 °C. Plasma samples were 
stored at −20 °C for biochemical analysis of glucose, proteins, 
albumin and enzymes (ALT, AST and ALP). 
Tissue preparation 
About 1 g of the liver was homogenized in 2 ml of buffer solution of 
phosphate buffered saline 1:2 (w/v; 1 g tissue with 2 ml PBS, pH 
7.4). Homogenates were centrifuged at 10,000 ×g for 15 min at 4 °C, 
and the resultant supernatant was used for the determination of 
Malondialdehyde (MDA), reduced glutathione and protein levels in one 
hand, and for measuring the activity of GST and GPx, in the other hand. 
Determination of glucose, protein, albumin and enzymes 
Plasma glucose level was assayed with a commercial kit (Spinreact, 
Spain, ref: 41011) and determined by an enzymatic colorimetric 
method using glucose oxidase enzyme. However, plasma albumin 
and total protein levels were determined by the colorimetric 
methods using kits from (Spinreact, refs: albumin-1001020, total 
proteins-1001291). The transaminases (alanine transaminase — ALT 
and aspartate transaminase—AST) and alkaline phosphatase (ALP) 
activities were assayed using commercial kits from Spain, refs: GOT-
1001165, GPT-1001175, and ALP-1001131, respectively). 
Determination of Malondialdehyde level (MDA) 
The lipid peroxidation level in liver homogenate was measured as 
malondialdehyde (MDA) which is the end product of lipid 
peroxidation and reacts with thiobarbituric acid (TBA) as a TBA-
reactive substance (TBARS) to produce a red colored complex with a 
peak absorbance at 532 nm according to Buege and Aust [24]. Thus, 
125 μl of supernatant were homogenized by sonication with 50 μl of 
PBS, 125 μl of TCA–BHT (trichloroacetic acid–butylhydroxytoluene) 
in order to precipitate proteins, and then centrifuged (1000 × g, 10 
min, and 4 °C). Afterward, 200 μl of supernatant were mixed with 
40 μl of HCl (0.6 M) and 160 μl of TBA dissolved in Tris, and then the 
mixture was heated at 80 °C for 10 min. The absorbance of the 
resultant supernatant was obtained at 530 NM. The amount of 
TBARS was calculated using a molar extinction coefficient of 
1.56×105 M/cm. 
Determination of reduced glutathione 
Liver GSH content was estimated using a colorimetric technique, as 
mentioned by Ellman (1959), modified by Jollow et al. [25], based on 
the development of a yellow colour when DTNB [(5,5 dithiobis-(2-
nitrobenzoic acid)] is added to compounds containing sulfhydryl 
groups. In brief, 0.8 ml of liver supernatant was added to 0.3 ml of 
0.25% sulfosalicylic acid; then tubes were centrifuged at 2500×g 
for 15 min. Supernatant (0.5 ml) was mixed with 0.025 ml of 0.01 M 
DTNB and 1 ml phosphate buffer (0.1 M, pH 7.4). The absorbance at 
412 nm was recorded. Finally, total GSH content was expressed as n 
mol GSH/mg protein. 
Determination of glutathione-S-transferase 
Glutathione-S-transferase (GST) (EC 2.5.1.18) catalyzes the 
conjugation reaction with glutathione in the first step of the 
mercapturic acid synthesis. The activity of GST was measured 
according to the method of Habig et al. [26]. The P-nitrobenzyl 
chloride was used as substrate. The absorbance was measured at 
340 nm at 30 s intervals for 3 min. 
Determination of glutathione peroxidase 
Glutathione peroxidase (GPx) (E. C.1.11.1.9) activity was measured 
by the procedure of Flohe and Gunzler [27]. Supernatant obtained 
after centrifuging 5% liver homogenate at 1500 ×g for 10 min 
followed by 10,000 ×g for 30 min at 4 °C was used for GPx assay. 1 
ml of the reaction mixture was prepared which contained 0.3 ml of 
phosphate buffer (0.1 M, pH 7.4), 0.2 ml of GSH (2 mM), 0.1 ml of 
sodium azide (10 mM), 0.1 ml of H2O2(1 mM) and 0.3 ml of liver 
supernatant. After incubation at 37 °C for 15 min, the reaction was 
terminated by addition of 0.5 ml 5% TCA. Tubes were centrifuged at 
1500 × g for 5 min, and the supernatant was collected. 0.2 ml of 
phosphate buffer (0.1 M pH 7.4) and 0.7 ml of DTNB 
(0.4 mg/ml) were added to 0.1 ml of reaction supernatant. After 
mixing, absorbance was recorded at 420 nm. 
Protein estimation 
The protein contents of various samples were determined according to 
the method of Bradford [28] by using bovine serum albumin as a 
standard. 
Statistical analysis 
Data were expressed as means±SEM. Data comparisons were carried 
out by using one-way analysis of variance followed by Student's t-
test to compare means between the different treated groups. 
Differences were considered statistically significant at p ≤0.05. 
RESULTS 
Effect of treatments on protein levels  
Treatment of rats with AS-induced significant reduction in the total 
protein level and albumin level as compared to a normal control 
group. Meanwhile, Ng treated rat’s elicited non-significant changes 
in both total protein and albumin levels as compared to a normal 
control group. Rats treated with a combination of AS and Ng 
afforded a significant decrease in total protein level and albumin as 
compared to control group. While affording a significant increase in 
both levels as compared to As treated group table (1) and fig. (1). 
 
Table 1: Changes in the protein level of control groups, naringenin (Ng) treated group, arsenic group (As) and naringenin co-administered 
with arsenic after 4 w of treatment 
Group (n=10) mean±SE  
Parameters Control Sodium Arsenate (As) Naringenin (Ng) As+Ng 
Total protein (g/l) 7.53±0.24a 4.68±0.25c 7.55±0.98a 6.01±0.47b 
Albumin (g/l) 4.25±0.24b 2.41±0.11d 4.68±0.39ab 3.87±0.87c 
*Means followed by the same letter are not significantly different at the α=0.05 level 
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Fig. 1: The protein level of control groups, (Ng) treated group, (As) 
group and (Ng) co-administrated with (As) after 4 w of treatment 
 
Effect of treatments on blood glucose level 
Administration of AS to rats afforded a significant increase in blood 
glucose level in As treated group. Meanwhile, Ng elicited a non-
significant increase in glucose level as compared to a normal control 
group. The group treated with a combination of As and Ng showed a 
marked reduction in blood glucose level as compared to As treated 
group as shown in the table (2) and fig. 2. 
 
 
Fig. 2: Blood glucose level of control and rats treated with 
naringenin (Ng), (As) and (Ng) co-administrated with (As) after 
4 w of treatment 
 
Effect of treatments on Liver enzymes biomarkers 
Treatment with As caused a significant increase in the activities of 
AST, ALT, and ALP as compared to the control (table 3) and fig. (3). 
However, treatment with Ng alone induced non-significant changes 
in the activities of AST, ALT and ALP compared to the control. In 
addition, Ng coadministered with As caused a marginal change in 
AST, ALT, and ALP as compared to the control. The content of 
plasma glucose of the As-treated group tended to be elevated. 
Compared to the control, albumin and protein levels in As-treated 
animals were diminished, but the co-administration of Ng with AS 
has produced a recovery in the above mentioned biochemical 
variables. 
 
Fig. 3: Liver enzymes biomarkers of control groups, (Ng) treated 
group, (As) group and (Ng) coadministered with (As) after 4 w 
of treatment 
 
Effects of treatments on hepatic oxidative stress parameters 
Exposure to As produced significant adverse effects on the liver 
redox status, which is evidenced by a significant depletion in the 
reduced glutathione GSH level, SOD activity, CAT activity, GPx 
activity and a significant increase in GST activity. These changes 
were accompanied by a highly significant increase in MDA level. 
However, administration of Ng only had no effect on these variables 
in normal animals and its parameters to be near normal. On the 
other hand, the co-administration of Ng–As produced recovery in the 
above mentioned hepatic oxidative stress parameters table 2 and 
(fig. 2 and 3). 
 
 
Fig. 4: SOD and CAT activities of control groups, naringenin (Ng) 
treated group, Arsenic (As) group and (Ng) co-administrated 
with (As) after 4 w of treatment 
 
Table 2: Changes in biochemical parameters of control group, naringenin (Ng) treated group, arsenic group (As) and naringenin co-
administered with arsenic after 4 w of treatment 
Group (n=10) mean±SE 
Parameters Control Sodium Arsenate (As) Naringenin (Ng) As+Ng 
Glucose (mg/dl) 118.35±2.36c 145.36±4.25a 119.57±3.74c 130.74±1.57b 
*Means followed by the same letter are not significantly different at the α=0.05 level 
 
Table 3: Changes in biochemical parameters of control groups, naringenin (Ng) treated group, arsenic group (As) and naringenin co-
administered with arsenic after 4 w of treatment 
Group (n=10) mean±SE 
Parameters Control Sodium Arsenate (As) Naringenin (Ng) As+Ng 
AST (U/l) 14.65±0.74cd 130.64±2.32a 13.25±0.68d 101.65±3.65b 
ALT (U/l) 13.10±0.68c 110.86±1.58a 13.24±0.55c 75.64±1.98b 
ALP (U/l) 35.87±1.02cd 225.79±2.63a 34.68±0.47d 170.36±4.25b 
*Means followed by the same letter are not significantly different at the α=0.05 level 
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Table 4: Changes in antioxidant enzymes and MDA level in liver homogenates of control and rats treated with naringenin (Ng), arsenic 
(As) and naringenin co-administrated with arsenic after 4 w of treatment 
Group (n=10) mean±SE 
Parameters Control Sodium Arsenate (As) Naringenin (Ng) As+Ng 
MDA (μmol/mg protein) 11.36±1.02cd 81.24±3.24a 10.12±1.12d 42.37±1.87b 
SOD (U/g) 23.65±2.36b 7.35±0.35d 24.35±1.57ab 10.65±0.59c 
CAT (U/g) 33.52±3.65b 11.65±0.41d 35.64±2.64ab 20.35±1.35c 
GPX (μmol/mg protein) 22.35±2.41b 5.24±0.35d 23.14±2.35ab 12.35±0.98c 
GSH (μmol/mg protein) 16.22±1.34b 7.52±1.02d 16.52±2.41ab 11.67±1.02c 
GST (nmol/min/mg protein) 2.15±0.11c 6.25±1.02a 2.05±0.35c 4.03±0.68b 
*Means followed by the same letter are not significantly different at the α=0.05 level 
 
 
Fig. 5: GPX, GSH, GST and MDA levels of control groups, 
naringenin (Ng) treated group, Arsenic (As) group and (Ng) co-
administrated with As after 4 w of treatment 
 
DISCUSSION 
Accordingly, among the main approaches used to ameliorate As-
induced hepatotoxicity is the use of agents with powerful 
antioxidant properties. In this context, recent studies have reported 
that the administration of naringenin (50 mg/kg) significantly 
preserved the hepatic function against the toxic effects exerted by 
heavy metals. Thus, animals injected with Ng have increased the 
excretion of As–Ng compounds in the bile and reduced hepatic 
arsenite concentrations [29].  
However, the in vitro study [30] has shown that during its cycles 
between different oxidation states, As generates reactive oxygen 
species (ROS) and causes organ toxicity. Consequently, ROS directly 
react with cell biomolecules, causing damages to lipids, proteins, and 
DNA, and hence leading to cell death [31, 32] and this finding is 
greatly in agreement with the obtained results. Due to its sulfhydryl 
group binding capability, As can also inhibit the activities of many 
enzymes, especially those involved in the cellular glucose uptake, 
gluconeogenesis, fatty acid oxidation and production of glutathione [33]. 
In the present study, a significant decrease in plasma proteins and 
albumin levels were recorded in As treated group. The decrease in 
the protein concentration of As-treated rats might be due to changes 
in protein synthesis and/or metabolism [34]. These results were in 
agreement with other findings [35]. Furthermore, the rise in blood 
glucose in As treated group may indicate a disrupted carbohydrate 
metabolism resulting from enhanced breakdown of liver glycogen, 
possibly mediated by an increase in adrenocorticotropic and 
glucagon hormones and/or reduced insulin activity [36].  
The administration of Ng with As has protected the liver function 
from As intoxication as indicated by the significant restoration of 
plasma biochemical indicators such as glucose, proteins, and 
albumin. 
The liver is the target organ of As toxicity [37], and the leakage of 
hepatic enzymes such as ALT, AST and ALP are commonly used as an 
indirect biochemical index of hepatocellular damage [38]. In the 
present finding, As intoxication caused a significant increase in the 
activities of ALT, AST, and ALP, probably resulting from hepatocyte 
membrane damage. If the liver is injured, its cells spill out the 
enzymes into the blood. These results are consistent with the 
previous findings released by some research groups who had found 
an association between As toxicity and the increased oxidative stress 
in rats [39].  
Though, the beneficial role of Ng in reducing oxidative stress 
parameters in the present study might be related to its mild 
antioxidant potential. It is known that As induces free radical 
formation either through direct promotion of free radical generation 
[40] or the inhibition of antioxidant enzymes [41]. However, lipid 
peroxidation is a basic cellular deteriorating process induced by 
oxidative stress and occurs readily in the tissues rich in highly 
oxidizable polyunsaturated fatty acids [43]. 
A primary measure of oxidative damage in the liver is lipid 
peroxidation, where MDA is measured as and the index of lipid 
peroxidation. In this work, there is a significant increase in MDA 
levels of rat liver treated with As compared to the control. It is 
known that As exposure generates various toxic radicals as the 
superoxide radical and also generates nitrogen species as the 
peroxynitrite and nitric oxide [44]. Thus, radicals are known to 
destabilize cell membranes as a result of lipid peroxidation [45].  
The increased lipid peroxidation observed in this study after As 
treatment could implicate the oxidative stress in As-induced 
hepatotoxicity [41]. It was found that the co-administration of Ng in 
the present study, which given at 50 mg/kg body weight in As 
induced toxicity has protected the liver from lipid peroxidation and 
from any changes in GSH and antioxidant enzymes like SOD and CAT 
[42]. 
This finding could be explained by the important role of Ng in 
preventing hydroxyl radicals' formation and in protecting the 
integrity and the functions of tissues like other antioxidant elements 
like Se [46]. Such results are in a good accordance with those 
obtained by Fredric et al. [47] More recently, it has been 
demonstrated that the in vivo antagonism between As and Se has its 
molecular basis in the formation of a novel As–Se compound: seleno-
bis (S-glutathionyl) arsinium ion, [(GS)2 AsSe]−, which are 
subsequently excreted in bile. The detection of [(GS)2 AsSe]− in bile 
after intravenous injection of rabbits with Se and As have suggested 
that both metalloids are first translocated to the liver [13] and thus, 
the present study to my knowledge is considered as the first paper 
to discuss the protective effect of Ng alone against the toxicity 
induced by As. 
Arsenic exerts its toxic effects due to its direct binding with–SH 
groups or indirectly through the generation of ROS [15]. ROS like 
hydrogen peroxide, hydroxyl radical species, nitric oxide or 
superoxide anion, dimethyl arsenic peroxyl radical, and dimethyl 
arsenic radical are known to be generated on arsenic exposure [12]. 
A direct correlation exists between the intracellular peroxide level 
and arsenic-induced cellular apoptosis with the role of glutathione 
(GSH) in the protection of arsenic-induced oxidative damage. An 
increase in lipid peroxidation accompanied by a decrease in cellular 
GSH contents has been suggested as one of the mechanisms of 
arsenic toxicity in female rats [41].  
Glutathione-related enzymes, such as glutathione peroxidase (GPx) 
and glutathione reductase (GR) function either directly or indirectly 
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as antioxidant, whereas glutathione S-transferase (GST) plays an 
important role in metabolic detoxification. Based on these 
observations, it is obvious that the use of antioxidants provides a 
viable and novel option for the arsenic treatment. Oxidative stress is 
a common mechanism contributing to the initiation and progression 
of hepatic damage in a variety of liver disorders. The aim of the 
present investigation was to evaluate the efficacy of flavonoids 
naringenin as a hepatoprotective and an antioxidant against arsenic-
induced hepatocellular damage.  
Flavonoids are naturally occurring substances that possess various 
pharmacological actions and therapeutic applications [48]. Some of 
these, due to their phenolic structures, have antioxidant effects and 
inhibit free radical-mediated processes. The essential activity of Ng 
is an antioxidant effect of its flavonolignans and of another 
polyphenolic substituent, which is attributed to the radical 
scavenging ability of both free radicals and reactive oxygen species 
(ROS) [49].  
Antioxidant, metal chelating, and free radical scavenging property of 
naringin have also been reported earlier [50]. The present results 
show that chronic arsenic exposure causes a significant increase in 
blood ROS levels, suggesting that free radicals were involved in 
oxidative stress. In addition to this, reduction in blood GSH level also 
supports arsenic-induced oxidative stress. The treatment with 
naringenin was able to reverse the trend.  
Lipid is considered as an index to monitor the function of membrane 
integrity while MDA (the end product of LPO) is measured as the 
index of lipid peroxidation [51]. In the present investigation, there 
was a marked increase in MDA levels in the arsenic exposed rats, 
which was substantially reduced after administration of naringenin. 
The preventive properties of naringenin have been related to the 
inhibition of lipid peroxides formation or scavenging of free radicals 
as evident from the decreased MDA level.  
The hepatic glutathione levels were decreased following arsenic 
administration, which was reversed following flavonoid treatment (Ng), 
which supports the antioxidant nature of the flavonoid. Antioxidant 
enzymes are considered to be the body’s primary defense, which 
prevents biological macromolecules from oxidative injury and removes 
peroxides, free radicals, and superoxide anion generated within the cell. 
Glutathione peroxidase (GPx) and catalase are the major enzymes that 
remove hydrogen peroxide generated by superoxide dismutase in 
cytosol and mitochondria by oxidizing GSH to GSSG [52]. 
GSH acts as a multifunctional intracellular non-enzymatic 
antioxidant and protects cells against several toxic active oxygen-
derived chemical species. It is considered to be an important 
scavenger of free radicals and a cofactor of several detoxifying 
enzymes against oxidative stress, e. g., glutathione peroxidase, 
glutathione-S-transferase and others [53].  
In the study there is observed a significant depletion of GPx, catalase 
and superoxide dismutase (SOD) activities in liver, following arsenic 
exposure. The function of SOD is to catalyze the dismutation reaction 
of O2-to generate H2O2, whereas catalase is involved in the 
decomposition of H2O2 to water and oxygen. The decrease in SOD 
activity may be attributed to enhanced superoxide radical 
production during arsenic metabolism [54].  
Moreover, the effect of arsenic on SOD has also been attributed to (i) 
altered SOD expression (ii) modification of cellular antioxidant 
uptake, GSH and vitamin depletion or (iii) alteration in an 
antioxidant activity by affecting their structure (oxidation/reduction 
of thiol group and displacement of essential metals) [55]. The 
increase in superoxide radicals also inhibits catalase activity. The 
minute NADPH production during arsenic exposure also decreases 
catalase activity [56].  
Since the polyphenols are known to inhibit the activity of GST 
enzymes, there may be a competition between the two for the active 
site of the enzyme. One of the most interesting observations in the 
present study has been the ability of the flavonoid of naringenin to 
reduce arsenic uptake in the target tissues. Co-administration of Ng 
at a dose of 50 mg/kg reduces significantly lipid peroxidation, 
arsenic uptake in liver tissues of animals exposed to arsenic. 
Combining the results of the study, there is no exclude of the 
possibility of a decreased arsenic absorption when polyphenols are 
supplemented in the diet. However, further experimentation needs 
to be done to find a possible mechanism by which plant polyphenols 
diminish tissue levels of arsenic. 
In conclusion, this study demonstrates that exposure to As provoked 
hepatotoxicity by inducing lipid peroxidation and depletion in 
antioxidant enzyme activities of rats. However, Ng treatment could 
protect the liver against As toxicity by reducing MDA level and 
increasing the activities of antioxidant enzymes and adjusting the 
level of liver enzymes biomarkers.  
CONCLUSION 
In view of the data of the present study, it can be concluded that 
arsenic (As) induced liver damage and remarkable oxidative stress. 
As exposure induced marked elevations in MDA level and alterations 
in antioxidant enzymes (SOD, CAT and Gpx) in liver tissues and 
afforded significant elevation in liver enzymes. Therefore, the 
changes in liver functions could be due to the generation of ROS, which 
causing damage to cell components. On the other hand, the treatment 
of rats with naringenin (Ng) ameliorated the antioxidant enzymes 
markers and improved the liver function parameters, and the 
combination between Ng and As significantly reduced the elevated 
liver enzymes and improved antioxidant capacity of liver tissues. 
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